Document Detail


Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.
MedLine Citation:
PMID:  2040689     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The role of nitric oxide in basal vasomotor tone and stimulated endothelium-dependent dilations in the coronary arteries in chronically instrumented awake dogs was studied by examining the consequences of inhibiting endogenous nitric oxide formation with the specific inhibitor of nitric oxide formation, NG-monomethyl-L-arginine (L-NMMA). In four awake dogs, coronary dimension crystals were chronically implanted on the circumflex artery for the measurement of epicardial coronary diameter, and Doppler flow probes were implanted for quantitation of phasic coronary blood flow (vasomotion of distal regulatory resistance vessels). Basal epicardial coronary diameter, acetylcholine-stimulated endothelium-dependent dilation, and flow-induced endothelium-dependent dilation of the epicardial arteries and phasic blood flow were recorded before, and after 5, 15, 50, and 120 mg/kg of L-NMMA. L-NMMA induced a dose-related increase in basal epicardial coronary vasomotor tone. There was an accompanying increase in aortic pressure and a decrease in heart rate. At doses greater than or equal to 50 mg/kg, rest phasic coronary blood flow was also decreased. Left ventricular end-diastolic pressure and contractility were not significantly changed. In contrast, the flow-induced or acetylcholine-stimulated endothelium-dependent responses were attenuated only after infusion of the highest does of L-NMMA (120 mg/kg). The changes in the basal vasomotor tone and acetylcholine-stimulated endothelium-dependent responses returned towards the control states in the presence of L-arginine (660 mg/kg). These data support the view that nitric oxide plays a significant role in modulating basal vasomotion and endothelial-dependent dilation stimulated by acetylcholine or increase in blood flow in epicardial coronary arteries and also influence the regulation of coronary blood flow during physiologic conditions.
Authors:
A Chu; D E Chambers; C C Lin; W D Kuehl; R M Palmer; S Moncada; F R Cobb
Related Documents :
9878319 - Acetylcholine-induced and nitric oxide-mediated vasodilation in burns.
18772009 - Physiologic stress-mediated signaling in the endothelium.
1360559 - Impaired endothelium-dependent vasodilation of forearm resistance vessels in hyperchole...
15355459 - Changes in endothelium-dependent arterial dilation before and after subtotal thyroidect...
7602489 - Femoral vasodilation to cromakalim is blocked by u37883a, a non-sulphonylurea that sele...
3123499 - Role of prostaglandins in blood-induced vasoconstriction of canine cerebral arteries.
21255589 - Accuracy evaluation of rbc velocity measurement in nail-fold capillaries.
23643329 - International challenges of self-sufficiency in blood products.
25322859 - Evaluation of esophagogastric varices after adult-to-adult living donor liver transplan...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of clinical investigation     Volume:  87     ISSN:  0021-9738     ISO Abbreviation:  J. Clin. Invest.     Publication Date:  1991 Jun 
Date Detail:
Created Date:  1991-07-10     Completed Date:  1991-07-10     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7802877     Medline TA:  J Clin Invest     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1964-8     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Duke Medical Center, Durham, North Carolina.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylcholine / pharmacology
Animals
Arginine / analogs & derivatives,  pharmacology
Coronary Circulation / drug effects
Coronary Vessels / physiology*
Dogs
Dose-Response Relationship, Drug
Endothelium, Vascular / physiology*
Hemodynamics / drug effects
Nitric Oxide / metabolism*
Regional Blood Flow
Vasomotor System / physiology*
Wakefulness
omega-N-Methylarginine
Grant Support
ID/Acronym/Agency:
HL 42562/HL/NHLBI NIH HHS; IROL HL 17670/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
10102-43-9/Nitric Oxide; 17035-90-4/omega-N-Methylarginine; 51-84-3/Acetylcholine; 74-79-3/Arginine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal...
Next Document:  Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormon...